Deferasirox 360 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F62P4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,649
Award facts
- Contract value 100% obligated
- $21,649.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $21,649.14 delivery order to AmerisourceBergen Drug Corp for the supply of Deferasirox 360 mg tablets (30-count units) under a firm fixed-price contract with an ultimate completion date of December 3, 2025. This non-competitive set-aside delivery order leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Health Agency and related government healthcare entities.
Deferasirox is an iron chelation therapy medication used to treat chronic iron overload conditions, representing the type of specialized pharmaceutical product that AmerisourceBergen regularly supplies through its DLA contracts. This delivery order is one of numerous competitively awarded transactions under the company's prime IDC, which encompasses a comprehensive portfolio including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The firm fixed-price structure and completion timeline demonstrate the company's operational capability to fulfill urgent federal medical supply requirements on compressed schedules.
Quick answers
Who was awarded contract SPE2DR26F62P4?
SPE2DR26F62P4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26F62P4 worth?
The government has obligated $21,649 on SPE2DR26F62P4.
Is contract SPE2DR26F62P4 an order under another contract?
Yes. SPE2DR26F62P4 is a delivery order under SPE2DR25D3303, an indefinite delivery contract.
Was contract SPE2DR26F62P4 competed?
The extent of competition for SPE2DR26F62P4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award